Andrew Booth Insider Profile
11 Followers
Andrew Booth, CFO at AbCellera Biologics, holds 613.76K shares in AbCellera Biologics (Ticker: ABCL). Most recently, Andrew Booth Bought 37,200 shares of AbCellera Biologics on Aug 14, 2026 for an estimated value of $383.90K.
Profitable Transactions
1 out of 5 Profitable Transactions
Average Return
+26.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
CFO
Roles that Andrew Booth holds in companies
Most Profitable Insider Trade
The most profitable trade made by Andrew Booth
Andrew Booth's Trading History
List of latest transactions for each holding click on a transaction to see Andrew Booth's performance on stock
You May Also Like
Andrew Booth insider profile FAQ
What is the percentage of profitable transactions made by Andrew Booth?
The percentage of profitable transactions made by Andrew Booth is 20%.
What is the average return per transaction made by Andrew Booth?
The average return per transaction made by Andrew Booth is 26.40%.
What stocks does Andrew Booth hold?
Andrew Booth holds: ABCL stocks.
What was Andrew Booth’s latest transaction?
Andrew Booth latest transaction was an Informative Buy of $383.90K.
What was Andrew Booth's most profitable transaction?
Andrew Booth’s most profitable transaction was an Informative Buy of ABCL stock on February 27, 2026. The return on the trade was 214.40%.
What is Andrew Booth's role in AbCellera Biologics?
Andrew Booth's role in AbCellera Biologics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.